Ranakusuma T A, Tobing S M, Almatsier M, Soemargo S
Ann Acad Med Singap. 1981 Oct;10(4 Suppl):15-20.
Beta-blockers are now well established treatment for hypertension. The prognosis of CVD is influenced by the presence of hypertension and coronary artery disease; both have an effect on cerebral perfusion pressure. Acebutolol was compared with oxprenolol in the treatment of 17 CVD patients with hypertension of long standing, 14 of whom had cardiac abnormalities and 16 retired abnormalities. Both drugs produced satisfactory lowering of blood pressure and there was no significant difference between their hypotensive effects. No adverse neurological complications occurred during treatment with either drug. Side-effects, CNS and gastrointestinal, of oxprenolol treatment were more frequent than with acebutolol. One patient receiving oxprenolol suffered bronchospasm. Both drugs produced a beneficial effect on neurological deficit.
β受体阻滞剂现已成为治疗高血压的成熟疗法。心血管疾病(CVD)的预后受高血压和冠状动脉疾病的影响;二者均对脑灌注压有影响。对17例长期患有高血压的心血管疾病患者进行了醋丁洛尔与氧烯洛尔的对比治疗,其中14例有心脏异常,16例有视网膜异常。两种药物均能使血压令人满意地降低,它们的降压效果无显著差异。使用这两种药物治疗期间均未发生不良神经并发症。氧烯洛尔治疗的中枢神经系统和胃肠道副作用比醋丁洛尔更常见。一名接受氧烯洛尔治疗的患者发生了支气管痉挛。两种药物均对神经功能缺损产生了有益影响。